Furthermore, in mice subjected to genetic ablation, the combination of CD36−/− CD8+T cells and anti-PD-1 antibody achieved better anti-tumor effect and prolonged mouse survival than the combination of WT CD8+T cells and anti-PD-1 antibody or CD36−/− CD8+T cells [40]. The gene discussed is CD8A; the disease is neoplasm.